Herantis Pharma (OHEL:HRTIS) Accounts Payable: €0.58 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OHEL:HRTIS Herantis Pharma PLC OHEL:HRTIS
24 GF Score
Price €1.56
! 3 Warning Signs
View Full Analysis

What is Herantis Pharma Accounts Payable?

Herantis Pharma OHEL:HRTIS +2.31% 24 Accounts Payable is €0.58 Mil as of Jun. 2026. GuruFocus rates OHEL:HRTIS with a GF Score™ of 24/100. The stock has 3 warning signs investors should review.

Herantis Pharma's Accounts Payable for the quarter that ended in Jun. 2026 was €0.58 Mil.

Herantis Pharma's quarterly Accounts Payable increased from Jun. 2025 (€0.28 Mil) to Dec. 2025 (€0.39 Mil) and increased from Dec. 2025 (€0.39 Mil) to Jun. 2026 (€0.58 Mil).

Herantis Pharma's annual Accounts Payable declined from Dec. 2023 (€0.75 Mil) to Dec. 2024 (€0.28 Mil) but then increased from Dec. 2024 (€0.28 Mil) to Dec. 2025 (€0.39 Mil).

Herantis Pharma Accounts Payable Related Terms

Herantis Pharma Accounts Payable Historical Data

* Premium members only.

The historical data trend for Herantis Pharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Herantis Pharma Accounts Payable Chart

Herantis Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.79 0.66 0.75 0.28 0.39

Herantis Pharma Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.28 0.28 0.39 0.58
OHEL:HRTIS
24GF Score
Herantis Pharma PLC OHEL:HRTIS
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Herantis Pharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €0.58 Mil mean?
Herantis Pharma (OHEL:HRTIS) has a Accounts Payable of €0.58 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Herantis Pharma and its competitors.
Is Herantis Pharma's Accounts Payable too high?
Herantis Pharma's current Accounts Payable is €0.58 Mil. Overall, Herantis Pharma has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Herantis Pharma's Accounts Payable compare to VRTX and REGN?
Herantis Pharma's Accounts Payable of €0.58 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Herantis Pharma and its competitors. Herantis Pharma's current Accounts Payable is €0.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Herantis Pharma stock overvalued right now?
Herantis Pharma (OHEL:HRTIS) has a current Accounts Payable of €0.58 Mil. The current Accounts Payable is €0.58 Mil. Herantis Pharma's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Herantis Pharma (OHEL:HRTIS), the current Accounts Payable is €0.58 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Herantis Pharma Business Description

Address Bertel Jungin Aukio 1, Espoo, FIN, 02600
Herantis Pharma PLC is a biotech company developing disease-modifying therapies for Parkinsons disease. The company's current development program focuses solely on HER-096, which is a peptidomimetic molecule designed to retain the biological activity of the neuroprotective CDNF protein.
24GF Score

Get the complete analysis for OHEL:HRTIS

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.56
Price